Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LANTHEUS HOLDINGS, INC.

(LNTH)
  Report
Delayed Nasdaq  -  04:00 2022-12-07 pm EST
54.33 USD   -2.07%
12/06Lantheus Holdings Prices $500 Million Convertible Senior Notes Offering
MT
12/06Lantheus Holdings, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/06Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
CommuniquÚs de presse de la sociÚtÚ LANTHEUS HOLDINGS, INC.
12/06Lantheus Holdings, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/06Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senio..
GL
12/05Lantheus Holdings, Inc. : Entry into a Material Definitive Agreement, Termination of a Mat..
AQ
12/05Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior ..
GL
12/05Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior ..
AQ
11/29Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial
GL
11/29Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial
GL
11/28Lantheus Announces the Approval of DEFINITY« (Perflutren Lipid Microsphere) by China's ..
GL
11/28Lantheus Announces the Approval of DEFINITY« (Perflutren Lipid Microsphere) by China's ..
AQ
11/14Lantheus Holdings, Inc. : Entry into a Material Definitive Agreement, Other Events, Financ..
AQ
11/14Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agr..
GL
11/09Lantheus to Present at the Jefferies London Healthcare Conference
GL
11/03LANTHEUS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
11/03Lantheus : Reports Third Quarter 2022 Financial Results - Form 8-K
PU
11/03Lantheus Holdings : Q3 Earnings Snapshot
AQ
11/03Lantheus : Q3 2022 Reconciliation of GAAP to Non-GAAP Financial Measures
PU
11/03Lantheus Reports Third Quarter 2022 Financial Results
GL
10/20Lantheus To Host Third Quarter 2022 : 00 a.m. Eastern Time
GL
10/17Lantheus Presentations at the European Association of Nuclear Medicine Annual Meeting S..
GL
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotra..
GL
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds flurpiridaz PET Radiotracer C..
AQ
09/01Lantheus to Present at the Wells Fargo Healthcare Conference
GL
08/04LANTHEUS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
08/04Lantheus : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/04Lantheus Holdings : Q2 Earnings Snapshot
AQ
08/04Lantheus : Q2 2022 Reconciliation of GAAP to Non-GAAP Financial Measures
PU
08/04Lantheus Reports Second Quarter 2022 Financial Results
GL
08/04Lantheus Reports Second Quarter 2022 Financial Results
AQ
07/21Lantheus Holdings To Host Second Qua : 00 a.m. Eastern Time
GL
06/15Lantheus : Announces Promotion of Paul Blanchfield to Chief Operating Officer - Form 8-K
PU
06/15Lantheus Holdings, Inc. : Change in Directors or Principal Officers, Financial Statements ..
AQ
06/15Lantheus Announces Promotion of Paul Blanchfield to Chief Operating Officer
GL
06/15Lantheus Announces Promotion of Paul Blanchfield to Chief Operating Officer
AQ
06/13Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel..
GL
06/13Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel..
GL
06/13Lantheus' PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency Wh..
GL
06/13Lantheus' PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency Wh..
AQ
06/02Lantheus to Present at the Jefferies Healthcare Conference
GL
05/26Lantheus Announces Presentations Featuring PYLARIFY« (Piflufolastat F18), PYLARIFY AI&t..
GL
05/17Lantheus Holdings, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
AQ
05/16Lantheus Hosts Inaugural Investor Day
GL
05/16Lantheus Hosts Inaugural Investor Day
AQ
05/16Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological As..
GL
05/13Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD..
GL
05/13Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD..
AQ
05/11Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Can..
GL
05/11Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Can..
AQ
05/10Lantheus to Present at the UBS Global Healthcare Conference
GL
05/10Lantheus to Present at the UBS Global Healthcare Conference
AQ
05/02Lantheus Holdings, Inc. : Change in Directors or Principal Officers, Submission of Matters..
AQ
04/29Lantheus : Reports First Quarter 2022 Financial Results - Form 8-K
PU
04/29LANTHEUS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
04/29Lantheus Holdings : Q1 Earnings Snapshot
AQ
04/29Lantheus Holdings, Inc. Reports First Quarter 2022 Financial Results
GL
04/15Lantheus Holdings To Host First Quar : 00 a.m. Eastern Time
AQ
04/04Lantheus Appoints Jean-Claude Provost, MD as Interim Chief Medical Officer
GL
03/29Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
AQ
03/08Lantheus Holdings to Present at the Barclays Global Healthcare Conference
AQ
03/03Lantheus to Host Inaugural Investor Day
AQ
03/01Lantheus : Announces Appointment of Minnie Baylor-Henry as New Board Member - Form 8-K
PU
03/01Lantheus Holdings, Inc. : Change in Directors or Principal Officers, Financial Statements ..
AQ
03/01Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member
GL
02/24Lantheus, South Jersey rise; Discovery, Rent-A-Center fall
AQ
02/24Lantheus Holdings : Q4 Earnings Snapshot
AQ
02/24Lantheus : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K
PU
02/24LANTHEUS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
02/24Palette Life Sciences Enters Into an Agreement with Lantheus to Support the Promotion o..
AQ
02/24Lantheus : Q4 and Full Year 2021 Reconciliation of GAAP to Non-GAAP Financial Measures
PU
02/24Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
GL
02/23Lantheus Receives U.S. FDA Approval of New Manufacturing Facility
AQ
02/10Lantheus Announces Presentation Featuring PYLARIFY« (Piflufolastat F18) at the 2022 ASC..
GL
02/10Lantheus Holdings To Host Fourth Qua : 00 a.m. Eastern Time
GL
02/10Lantheus Holdings To Host Fourth Qua : 00 a.m. Eastern Time
GL
01/28Lantheus Collaborates with the Prostate Cancer Clinical Trial Consortium to Advance AI-..
AQ
01/27Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Adv..
AQ
1  2  3  4  5Next
Upcoming event on LANTHEUS HOLDINGS, INC.